Skip to main content
. Author manuscript; available in PMC: 2016 Jan 19.
Published in final edited form as: Mol Pharm. 2015 Dec 10;13(1):8–24. doi: 10.1021/acs.molpharmaceut.5b00626

Figure 2.

Figure 2

Five molecular imaging modalities employed for cancer screening and therapeutic monitoring includes positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance (MR), optical, and photoacoustic (PA) imaging. Adapted from Ref. 208–211 with permission.